Using RNA from a subset of samples from the Walker et al. study, we confirmed significant (p<0.05) upregulation of the ESRP1 gene in primary prostate cancer patients presenting with a metastatic biology (Figure 2C). This evidence concerns the gene ESRP1 and prostate carcinoma.